D&D Pharmatech Announces First Patient Dosed in Phase 1 Clinical Trial of DD01 in Obese …,

… announced dosing of the first patient in a Phase 1 clinical trial of DD01 in obese patients with diabetes and non-alcoholic fatty liver disease (NAFLD) …, … announced dosing of the first patient in a Phase 1 clinical trial of DD01 in obese patients with diabetes and non-alcoholic fatty liver disease (NAFLD) …, Read More

Scroll to Top